Breaking News

EpiPen CEO Tied to Democratic Senator
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

Mylan epipen

Summary: The CEO responsible for the manufacturing and overwhelming steep increase in cost of EpiPens is the daughter of Democratic Sen. Joe Manchin.

The daughter of U.S. Senator Joe Manchin, Democrat for West Virginia, is responsible for the hike in price for the life-saving EpiPens. His daughter Heather Bresch is the CEO of Mylan, a pharmaceutical company that produces EpiPens, an allergy injection pen.

  
What
Where


Nine years ago people could purchase the two-dose package for about $94. Since May, the cost is over six times that cost to be over $600 for the two-pack. The greatest increases in the drug have occurred in the last three years – from $265 to $609.

Read Wild Drug Price Hike Spurns Strong Reaction from Hillary Clinton.

This sudden cost has several senators requesting more information and for congressional hearings and investigations to take place. Sens. Richard Blumenthal of Connecticut and Amy Klobuchar of Minnesota are asking for the Federal Trade Commission to determine if the pharmaceutical company has violated antitrust laws.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




Mylan claims the increase is due to health insurance changes with higher deductibles. They state that most people have insurance to cover the cost and for those that don’t they offer a coupon to help cover the cost of co-payments.

See Retaliation Lawsuit Brought Against Mylan Pharmaceuticals by Ex-Employee.



The truth is that a 2012 lawsuit has required the release of a generic EpiPen into the market. Once the lawsuit was settled, Mylan jumped the price of injection pen up quickly. As many point out, Mylan has done nothing different than most drug companies do when a generic drug is about to be released. Companies attempt to suck as much profit as they can from the name-brand version before the generic is available.

A big problem is that the generic options have been rejected so there is no competition for the EpiPens yet. Mylan has a monopoly on the market and making a huge profit because of it.

Do you think companies should be allowed to raise the cost of drugs without justification of cost-of-living increases, shortage of supplies, etc.” Tell us in the comments below.

To learn more about another CEO that raised the cost of drugs, read Much Hated Pharmaceutical Exec Arrested on Fraud Charges.

Photo: money.cnn.com



 

RELEVANT JOBS

Compliance Associate

USA-NY-New York City

About Us: New datasets are being created every day and investors need to incorporate them to rema...

Apply now

Legal Assistant

USA-FL-Boynton Beach

Are you looking to expand your knowledge and experience in the legal world? If so, come join our ama...

Apply now

Personal Injury Attorney

USA-FL-Boynton Beach

Come join one of the fastest growing and successful injury law firms in Florida! Frankl Kominsky ...

Apply now

Litigation Paralegal

USA-CO-Colorado Springs

Seeking Litigation Paralegal for Personal Injury Law Firm Vigil and Alford, PLLC is seeking a par...

Apply now

BCG FEATURED JOB

Locations:

Keyword:



Search Now

BCG Attorney Search In-House Counsel

USA-CA-Los Angeles

BCG Attorney Search In-House Counsel We are a Legal Employment Company located in California with o...

Apply Now

FDA Regulatory Attorney

USA-MA-Boston

Boston office of a BCG Attorney Search Top Ranked Law Firm seeks FDA regulatory attorney with 3-4 ye...

Apply Now

Foreclosure/Bankruptcy Associate Attorney

USA-CA-Temecula

Temecula office of our client seeks associate attorney with preferably 2 years of experience working...

Apply Now

SEARCH IN ARCHIVE

To Top